title: Role of medullasin in nifedipine-induced gingival overgrowth in rats.
abstract: To clarify the possible pathophysiological role of medullasin, a neutrophil elastase-like proteinase, in nifedipine (NF)-induced gingival overgrowth, a rat model of gingival overgrowth was first established using a diet containing NF. The relation between histopathological changes and the distribution of the proteinase was then investigated. Thirty-two, specific pathogen-free 20 day-old, male, Fisher 344 rats were fed a diet containing NF and killed at 2, 8, 16 and 32 weeks. Control rats (n = 32) were fed the same diet but without the drug. The mandible of each rat was resected and sectioned at 4-microm thickness buccolingually between the first and second molars. Computer image analysis was used to evaluate the extent of overgrowth in the approximal gingiva of each sample. To examine medullasin activity, the mean percentage of medullasin-positive cells per total cells counted in the pocket epithelium and the connective tissue adjacent to the epithelium of approximal gingiva was determined immunohistochemically. The height of the mid-portion and the area in NF-treated group increased significantly with time (with the exception of area at 2 weeks) compared with the corresponding regions in the control group. A marked inflammatory-cell infiltration and elongated rete pegs, especially in the mid-portion of approximal gingiva, were seen in the NF-treated group. The mean percentages of medullasin-positive cells in the NF-treated group at 8, 16 and 32 weeks were significantly higher than those of the control. Although medullasin-positive cells were mainly neutrophils, in several samples of the NF-treated group they were recognized as macrophage-like. These findings suggest that medullasin may be involved in host defence and immunoregulation in a NF-induced rat model of gingival overgrowth.
authors.affiliation: Department of Periodontology, Nagasaki University School of Dentistry, Sakamoto, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Ozaki
authors.forename: K
authors.initials: K
authors.lastname: Kunimatsu
authors.forename: K
authors.initials: K
authors.lastname: Tajiri
authors.forename: Y
authors.initials: Y
authors.lastname: Hara
authors.forename: Y
authors.initials: Y
authors.lastname: Kato
authors.forename: Y
authors.initials: Y
authors.lastname: Aoki
authors.forename: I
authors.initials: I
authors.lastname: Kato
mesh_terms: D000818:Animals; D019214:Gingival Overgrowth / Q000139:chemically induced* / Q000201:enzymology* / Q000276:immunology; D007124:Immunoenzyme Techniques; D018836:Inflammation Mediators / Q000378:metabolism; D008264:Macrophages / Q000201:enzymology; D008297:Male; D009504:Neutrophils / Q000201:enzymology; D009543:Nifedipine / Q000009:adverse effects*; D051381:Rats; D011916:Rats, Inbred F344; D012697:Serine Endopeptidases / Q000378:metabolism*; D018709:Statistics, Nonparametric
chemical_list: D018836:Inflammation Mediators; D012697:Serine Endopeptidases; C034869:medullasin; D009543:Nifedipine